Theratechnologies
THTX
THTX was delisted on the 25th of September, 2025.
28 hedge funds and large institutions have $13.8M invested in Theratechnologies in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
26.47% more ownership
Funds ownership: 0% → 26.47% (+26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.99M |
| 2 |
Morgan Stanley
New York
|
+$4.84M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.72M |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$481K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$420K |
Top Sellers
THTX Hedge Fund Activity: Q3 2023 in Review
28 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Theratechnologies (THTX) for Q3 2023, worth a combined $13.8M.
Buyers outnumbered sellers: 28 funds opened new THTX positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Soleus Capital Management, opening a new position worth an estimated $4.99M.
- 28 institutional investors held Theratechnologies (THTX) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $13.8M of Theratechnologies stock for Q3 2023.
- 28 funds opened new Theratechnologies positions in Q3 2023 and 0 closed out, a net change of +28 holders.
- The largest Theratechnologies buyer in Q3 2023 was Soleus Capital Management, an estimated $4.99M added.
Based on aggregated 13F filings for Q3 2023.